Yipinhong Pharmaceutical
Market cap
$836m
Enterprise valuation
$947m (Public information from Sep 2024)
Share price
CNY12.89 300723.SZ
Guangzhou City Guangdong (HQ)
Financials
Estimates*
| CNY | 2019 | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|---|---|
| Revenues | 1.6b | 1.7b | 2.2b | 2.3b | 2.5b | 28.7b |
| % growth | - | 2 % | 31 % | 4 % | 10 % | - |
| EBITDA | 283m | 329m | 476m | 450m | 470m | - |
| % EBITDA margin | 17 % | 20 % | 22 % | 20 % | 19 % | - |
| Profit | 144m | 226m | 307m | 291m | 185m | - |
| % profit margin | 9 % | 13 % | 14 % | 13 % | 7 % | - |
| R&D budget | 98.0m | 135m | 142m | 190m | 301m | - |
| R&D % of revenue | 6 % | 8 % | 6 % | 8 % | 12 % | - |
